BLEEDING PATTERNS AND CONTRACEPTIVE DISCONTINUATION FG MHLANGA MTN ANNUAL MEETING 20 MARCH 2018

Similar documents
LARC: Disclosures. Long Acting Reversible Contraception. Objectives 10/23/2013. I have no relevant financial disclosures

What s New in Adolescent Contraception?

Review of IUCD Complications: Lessons from CAT. Dr FG Mhlanga CAT Meeting 24 September 2016

Disclosures CONTRACEPTION COUNSELING IN MEDICALLY COMPLEX ADOLESCENTS. Aletha Akers, MD, MPH and Lyndsey Benson, MD, MS

Maximizing LARC Availability: Bringing the Lessons of the CHOICE Project to Your Community

Contraception: Common Problems Faced in Office Practice. Jane S. Sillman, MD Brigham and Women s Hospital

Unintended Pregnancy in U.S. The Importance of LARC: What have We Learned? Long-acting Reversible Contraception (LARC)

Contraception for Obese Women RENEE E. MESTAD, MD, MSCI ACOG DISTRICT II UPSTATE MEETING APRIL 29, 2016

Table I. Examples of Hormone and Tapering Regimens

Instruction for the patient

Ardhanu Kusumanto Oktober Contraception methods for gyne cancer survivors

Medical Eligibility for Contraception Use

Unintended Pregnancy is Common LEARNING OBJECTIVES. Distribution Of Contraception Use By Women In The Us. Unintended Pregnancy And Contraceptive Use

Simplifying Vide Contraception. University of Utah Department of Ob/Gyn Post Grad Course February 13, 2017 David Turok

Contraception for Adolescents: What s New?

CONTRACEPTION OLD FRIENDS, NEW TRENDS

1. Ng M et a l. Global, regional, and national prevalence of overweight and obesity in children and adults during : A systematic analysis

Contraception Choices: An Evidence Based Approach Case Study Approach. Susan Hellier PhD, DNP, FNP-BC, CNE

Long-Acting Reversible Contraception: The Contraceptive CHOICE Project

Complex Medical Problems? Complex Contraception. Objectives 4/17/2015. Sari Kives, MD,FRCSC ; Alene Toulany, MD, FRCPC

LEARNING OBJECTIVES. Beyond the Pill: Long Acting Contraception. Distribution Of Contraception Use By Women In The Us. Unintended Pregnancy is Common

2

Global Contraception

Hormonal contraceptive methods & HIV acquisition in women: updated systematic review of epidemiological evidence

Progestin-only methods Type or dose of progestagen

Contraception and gynecological pathologies

CURRENT HORMONAL CONTRACEPTION - LIMITATIONS

Fertility control: what do women want?

BIOLOGICAL/IMMUNOLOGICAL CONSIDERATIONS MOVING TOWARD A 3-MONTH CONTRACEPTIVE DAPIVIRINE RING

Contraceptive Updates and Recommendations

Contraceptive Updates and Recommendations

An Overview of Long Acting Reversible Contraception Methods

Hormonal contraception and HIV risk

Multipurpose Intravaginal Ring: Tenofovir / Levonorgestrel

Contraception. Objectives. Unintended Pregnancy. Unintended Pregnancy in the US. What s the Impact? 10/7/2014

One-day Essentials Contraception. Dr Paula Briggs, General Practitioner, Clinical Lead Community Sexual Health, Sefton and West Lancashire

Dr. Nancy Van Eyk Associate Professor, Dalhousie University Chief of Gynaecology, IWK Health Centre

prevalence was 13.8% among females

Clinical Challenges in Contraception. Disclosures. Objectives Pharmacists 4/3/2018

BEST PRACTICES IN CONTRACEPTIVE COUNSELING

Learning Objectives. Expert Medical Advisory Committee. Acknowledgment. A Vignette-Based Approach to Addressing Hormonal Contraception.

Time Topic Speaker Abbreviation

Product Information. Confidence that lasts

Key words: Contraception, Copper T380A, Discontinuation.


Orals,Transdermals, and Other Estrogens in the Perimenopause

Emergency Contraception THE FACTS

Disclosures. Learning Objectives 4/18/2017 ADOLESCENT CONTRACEPTION UPDATE APRIL 28, Nexplanon trainer for Merck

BRIEF REPORTS. Providing Long-Acting Reversible Contraception in an Academic Family Medicine Center Jennifer Amico, MD, MPH; Justine Wu, MD, MPH

Impact of Learning HIV Status on Contraceptive Use in the MIRA Trial

Hormonal Contraception and HIV: The WHO Responds. Ward Cates MTN Annual Meeting February 21, 2012

Implants and ART: weighing the evidence to guide programs

2/4/2011. What is your specialty? A. Family practice B. Internal medicine and subs C. OB/GYN D. Peds E. Surgery and subs

LONG-ACTING REVERSIBLE CONTRACEPTION. Summary Tables

Long Acting Reversible Contraception: First Line Care for Adolescents. David A. Levine, MD, FAAP Melissa Kottke, MD, MPH, FACOG

Trudy Bush Lecture: Using Progestins in Clinical Practice. Progestins in Clinical Practice: Outline. NAMS Definitions. FDA Approved Oral Progestins

Linda Gregg NP, Janet Isabell NP, Sue Montei NP Clinical Reviewers Reproductive Health Unit

Hormonal Implants Technical Update June 23, Jeff Spieler Senior Technical Advisor for Science and Technology GH/PRH

Extended use of intrauterine devices: How long can we go?

HIV and contraception the latest recommendations

Hormonal Contraception: Asian View. Hormonal Contraception: Asian View: focused on Chinese View. Prof.Dr.Xiangyan Ruan, MD.PhD

Learning objectives. Some fun facts. Presenter Disclosure Information. Become familiar with the newest contraceptive options available

2

COLLECTION OF CRITICALLY APPRAISED TOPICS ON CONTRACEPTION

CONTRACEPTION DISCLOSURES OBJECTIVES ACKNOWLEDGEMENTS AND SEXUAL FUNCTION 10/21/2014

Summary of analysis of efficacy and safety of Implantable Contraceptives (levonorgestrel and etonogestrel releasing implants).

Final Report: Qualitative Interviews with Mirena Users and their Partners in Kenya

الحمد هلل رب العالمين والصالة والسالم علي محمد الصادق الوعد األمين اللهم أخرجنا من ظلمات الجهل والوهم إلى نور المعرفة والعلم..

The Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial

Disclosures. Contraceptive Method Use, U.S. Best Practices in Contraception: Advances, Tips, and Tricks

Learning objectives. Some fun facts. Presenter Disclosure Information. Discuss the newest contraceptive options available

Update on Medical and Surgical Therapy Sara Jane Pieper, MD Chair, Gynecology Development Team

Contraception IUS and Intradermal Implant

CLINICAL PEARLS IN CONTRACEPTION

FIGO and Prevention of Unsafe Abortion LARC and PM for PAC

ORIGINAL ARTICLE Fertility control. Submitted on January 2, 2014; resubmitted on March 21, 2014; accepted on April 1, 2014

WHAT ARE CONTRACEPTIVES?

The number of women using long-acting reversible

Picking the Perfect Pill How to Effectively Choose an Oral Contraceptive

BMI and Contraception: What s the Evidence?

Disclosures. Objectives. Case: Anna. Case: Carla. Case: Beth. Contraception (for the Family Physician) 5/22/2015. Valary Gass, MD.

Topics. Periods Menopause & HRT Contraception Vulva problems

CONTRACEPTION AND MISCONCEPTIONS CONTRACEPTION IN WOMEN WITH MENTAL ILLNESS

Nelson: Managing Side Effects and Complications Related to LARCs

Application for inclusion of levonorgestrel - releasing IUD for contraception in the WHO Model List of Essential Medicines

Expanding access to injectable contraceptives

The Balanced Counseling Strategy Plus: A Toolkit for Family Planning Service Providers Working in High STI/HIV Prevalence Settings.

Contraception & HIV Still searching for answers after >2 decades

Contraception. Yolanda Evans MD MPH Assistant Professor of Pediatrics Division of Adolescent Medicine

Contraception for young people. Dr Cindy Farmer Bristol Sexual Health Services Fri 8 th May 2015

Day of Learning: Current Best Practices for Contraceptive Provision

Birth Control- an Overview. Keith Merritt, MD. Remember, all methods of birth control are safer and have fewer side effects than pregnancy

1. Ortiz, M. E et al. Mechanisms of action of intrauterine devices. Obstet & Gynl Survey 1996; 51(12), 42S-51S.

Contraceptive case studies. Dr Christine Roke National Medical Advisor Family Planning June 2015

Nelly Mugo, MBChB, MMed, MPH Kenya Medical Research Institute. May 2015

U.S. Medical Eligibility Criteria for Contraceptive Use, 2010

Peggy Piascik, PhD Associate Professor, Pharmacy Practice and Science

Adolescent Hot Topics: Contraception

Contraception in Adolescents and Young Adults with a Chronic Illness

Comparison of NuvaRing and Desogen in IVF cycles with ganirelix acetate

Transcription:

BLEEDING PATTERNS AND CONTRACEPTIVE DISCONTINUATION FG MHLANGA MTN ANNUAL MEETING 20 MARCH 2018

Introduction Bleeding with contraception may lead to discontinuation and possible unintended pregnancy What are bleeding experiences amongst women using modern contraception? How can we manage expectations of bleeding patterns for women using progestin only contraceptives?

The history of bleeding with HC Early pills designed to mimic menstrual cycle Tri-phasic pills Withdrawal bleed every month Given observed VTE risk with higher dose pills, HC shifted to lower dose methods Now many methods that are progestin only

What does the estrogen do? The estrogens component is NOT responsible for the contraceptive efficacy Endometrial stability Improved bleeding patterns Over years, dose decreased from more than 150 mcg of ethinyl estradiol to 35 mcg or less. The lowest doses associated with the most bleeding episodes

Bleeding experiences with progestin-only contraceptive methods: pills Menstrual changes in >50%. irregular bleeding short cycles (caused by an inadequate luteal phase) amenorrhea 1.Hatcher RA. Contraceptive technology. 17th ed. rev. New York: Ardent Media, 1998:467 509. 2. Wallach M, Grimes DA, Chaney EJ, et al., eds. Modern oral contraception: updates from The Contraception Report. Totowa, N.J.: Emron, 2000:242 50.

Bleeding experiences with progestin-only contraceptive methods: injectables Unscheduled bleeds ~ 70% of women 1 st year Post I yr of DMPA use, up to 50% of women experience amenorrhea & may reach 80% with further use 1.Hatcher RA. Contraceptive technology. 17th ed. rev. New York: Ardent Media, 1998:467 509

Bleeding experiences with progestin-only contraceptive methods: implants Unscheduled bleeding in up to 80% of women Bleeds tend not to normalize over time but remain random and unpredictable throughout years of use. 1.Hatcher RA. Contraceptive technology. 17th ed. rev. New York 2. Darney P Fertil Steril. 2009;91(5): 3.Mansour D, Eur J Contracept Reprod Health Care. 2008;

Bleeding experiences with Copper IUDs Unscheduled in ~70% of new users first 3 to 6 months 1. Up to 50% increased menstrual blood loss with a NCS reduction in hemoglobin 2. Bleeding tendency decreases over time. 1.J Fam Plann Reprod Health Care. 2015;41(4) 2. Contraception. 1987;36(1):129 144

Bleeding experiences with LNG IUDs LNG-IUD- lighter menses/amenorrhoea that might take 3-6 months to establish

WHO Levonorgestrel IVR LNG ring previously developed & tested in women Low dose 20mcg/day and lasted 90 days Disappointing contraceptive efficacy 3.6 6.5 per 100wyrs 1,3 Bleeding concerns 2 Unscheduled~25% Prolonged~10% 1.Koetsawang S Contraception. 1990 Feb;41(2):151-67 2.Koetsawang S Contraception. 1990 Feb;41(2):105-24 3. Sahota J Adv Contracept. 1999;15(4):313-24.

Bleeding experiences with progestin-only contraceptive methods: IVRs? Nuvaring releases 15 µg of ethinyl estradiol and 120 µg of etonogestrel daily; continuous & cyclic use. Excellent cycle control similar/better than that of COCs 1 Unscheduled bleeding common in the first few months of use 2 1. Bjarnadottir RI, TuAm J Obstet Gynecol. 2002;186(3) 2.Speroff L, Darney PD. A Clinical Guide for Contraception. 5th ed. Philadelphia

Zimbabwe Experience High uptake of contraceptive use 66% 1 Most common reasons for method d/c: Unscheduled bleeding Perceived side effects 1. ZDHS 2015

Participant experience of unpredictable bleeding in ZIMCHIC Study Young (18-34yo), healthy women Enrolled participants (N=451) self-selected contraceptive method to start/use for 6 mo: Injectable (DMPA, MPA/EE, Net-En) Implant (ENG or LNG implant) Copper-T IUCD Evaluated satisfaction with chosen contraceptive and reasons for discontinuation Monitored Hgb over course of study

Demographics of Participants enrolled in the ZIMCHIC study. Important differences were noted in the copper IUD arm mostly being; single of low parity, living on their own without a sexual partner reduced coital frequency. Other sociodemographic characteristics similar across the study arms.

Frequency of Unscheduled Bleeding in ZIMCHIC 25 of 451 (5.5%) reported bleeding at any point after enrollment with no significant difference across the contraceptive arms; p= 0.11 14 12 10 8 6 4 2 0 Percentages of women reporting Abnormal Uterine Bleeding 3.8 2.5 5.6 6.2 2.8 13.2

Changes in haemoglobin.. There was no statistically significant changes in Hgb in women using any of the hormonal methods or the Copper IUCD In participants self-reporting abnormal bleeding: mean decrease in hemoglobin was -0.26 (NS)

Satisfaction with chosen ZIMCHIC method Highly satisfied with m ethod 100 Unscheduled bleeding was tolerable 75 % 50 25 0 DMPA MPA/E2 NET-En E N G -im p la n t LNG-im plant C u -IU D

Method Discontinuation 45 40 35 30 25 20 15 10 5 0 Percentage not continuing with contraceptive method chosen at enrollment Overall 120 of 411 (29.7%) opted to change Only 2.4% of these cited bleeding as reason Most cited reasons were: Opting for change (17.3%) Desires pregnancy (6.9%)

Counselling on expectations with contraception Canto De Cetina, Contraception 2001 350 women; DMPA 175 each arm, detailed vs routine counselling Unscheduled bleeds commonest discontinuation reason (17% vs 43%) Backman T, Obstet Gynecol 2002 18000 had IUD; 1990-1993, 70% following bad experience with prior contraceptive Satisfaction related to AE info given regardless of pt experiencing these

Summary Unscheduled bleeding with progesterone only contraception is common Overall bleeding is typically less with progestin only contraception relative to natural cycles Counselling aligned to bleeding expectations improves satisfaction and minimizes discontinuation.

Acknowledgements We sincerely thank the Bill and Melinda Gates Foundation for funding this study as well as the many participants who made this study possible.